Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Ribbon Communications
RBBN
$377M
| $473K | ﹤0.01% |
57,737
+35,734
| +162% | +$296K |
|
3177
Applied Optoelectronics
AAOI
$7.57B
| $471K | ﹤0.01% |
56,402
+14,608
| +35% | +$147K |
|
3178
CRA International
CRAI
$1.16B
| $471K | ﹤0.01% |
6,299
+2,406
| +62% | +$146K |
|
3179
PUT
Veeva Systems
VEEV
$33.1B
| $470K | ﹤0.01% |
1,800
| – | – |
|
|
CLLS
3180
Cellectis
CLLS
$277M
| $469K | ﹤0.01% |
23,216
+18,688
| +413% | +$462K |
|
3181
iShares Latin America 40 ETF
ILF
$3.85B
| $469K | ﹤0.01% |
16,991
+60
| +0.4% | +$1.7K |
|
|
HQH
3182
abrdn Healthcare Investors
HQH
$1.25B
| $468K | ﹤0.01% |
+18,731
| New | +$457K |
|
3183
ITT
ITT
$17.5B
| $468K | ﹤0.01% |
5,144
-38,854
| -88% | -$3.2M |
|
|
LEAF
3184
DELISTED
Leaf Group Ltd.
LEAF
| $468K | ﹤0.01% |
72,542
+62,351
| +612% | +$372K |
|
3185
Matrix Service
MTRX
$326M
| $467K | ﹤0.01% |
35,610
-13,122
| -27% | -$175K |
|
3186
Winmark
WINA
$1.2B
| $467K | ﹤0.01% |
2,509
+1,241
| +98% | +$226K |
|
3187
Chemed
CHE
$7.07B
| $466K | ﹤0.01% |
1,016
+172
| +20% | +$84.3K |
|
|
CAMP
3188
DELISTED
CalAmp Corp.
CAMP
| $466K | ﹤0.01% |
1,870
+194
| +12% | +$49.2K |
|
3189
Altimmune
ALT
$552M
| $464K | ﹤0.01% |
32,845
+4,545
| +16% | +$73.5K |
|
3190
CALL
Signet Jewelers
SIG
$3.61B
| $464K | ﹤0.01% |
8,000
-43,100
| -84% | -$2.02M |
|
|
HAYN
3191
DELISTED
Haynes International, Inc.
HAYN
| $464K | ﹤0.01% |
15,655
+1,713
| +12% | +$46.2K |
|
|
IGD
3192
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$517M
| $463K | ﹤0.01% |
+74,025
| New | +$403K |
|
3193
NCR Voyix
VYX
$1.14B
| $463K | ﹤0.01% |
19,876
+3,098
| +18% | +$68.1K |
|
3194
CEL-SCI Corp
CVM
$20.3M
| $462K | ﹤0.01% |
1,013
+650
| +179% | +$355K |
|
3195
Expro Ltd
XPRO
$1.79B
| $460K | ﹤0.01% |
21,593
+13,255
| +159% | +$288K |
|
3196
Astrana Health
ASTH
$1.76B
| $460K | ﹤0.01% |
16,960
+10,438
| +160% | +$251K |
|
3197
Global Industrial
GIC
$1.37B
| $459K | ﹤0.01% |
11,163
+1,578
| +16% | +$62.4K |
|
3198
Ennis
EBF
$552M
| $458K | ﹤0.01% |
21,447
+7,624
| +55% | +$151K |
|
3199
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.31B
| $458K | ﹤0.01% |
+3,469
| New | +$502K |
|
|
GSKY
3200
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $456K | ﹤0.01% |
73,754
+36,362
| +97% | +$209K |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.